--- name: conducting-psychiatric-evaluations language: en description: Structures comprehensive psychiatric evaluation with MSE, diagnostic formulation, and risk assessment. Use when performing psychiatric assessments, documenting mental status exams, or creating diagnostic formulations. tags: - process - psychiatry - risk - diagnostic metadata: author: casemark practice_areas: - Psychiatry - Psychology - Behavioral Health document_types: - Process Documentation skill_modes: - Process Management --- # Conducting Psychiatric Evaluations Structures comprehensive psychiatric evaluations with mental status examination, diagnostic formulation, and risk assessment in compliance with APA Practice Guidelines. ## Why This Skill Exists A comprehensive psychiatric evaluation is the foundation of all psychiatric treatment. Incomplete evaluations lead to missed diagnoses, inappropriate treatment, avoidable hospitalizations, and malpractice exposure. The APA Practice Guidelines for Psychiatric Evaluation of Adults (Third Edition) establish clear standards: evaluations must integrate chief complaint, history of present illness, psychiatric history, substance use history, medical history, family history, social/developmental history, mental status examination, risk assessment, and a multiaxial diagnostic formulation. Regulatory and accreditation bodies including The Joint Commission (TJC), CMS Conditions of Participation, and state licensing boards mandate specific documentation elements for psychiatric evaluations. Failure to document a thorough evaluation has been the primary basis for malpractice claims in psychiatry, particularly when patients experience adverse outcomes that were foreseeable from information that should have been elicited during intake. --- ## Checkpoint A: Pre-Draft Intake (Mandatory) 1. What is the clinical setting? (inpatient, outpatient, emergency department, forensic, consultation-liaison) — default: outpatient 2. What is the referral question? (diagnostic clarification, medication management, risk assessment, fitness for duty) — default: diagnostic clarification 3. Is this an initial evaluation or follow-up reassessment? — default: initial 4. What is the patient's age group? (child/adolescent, adult, geriatric) — default: adult 5. Are there known safety concerns requiring immediate risk assessment? — default: unknown, assess at intake 6. What collateral sources are available? (family, prior records, referring provider notes) — default: none confirmed 7. What standardized instruments have been administered or are requested? (PHQ-9, GAD-7, PCL-5, AUDIT-C, Columbia Suicide Severity Rating Scale) — default: PHQ-9 and GAD-7 8. What is the expected output format? (narrative report, structured template, EHR-compatible note) — default: structured template ### Documents to Request - Prior psychiatric evaluation reports and discharge summaries - Current medication list including dosages and prescribing dates - Primary care records including recent lab work (TSH, CBC, CMP, lipid panel, HbA1c) - Prior psychological testing reports (neuropsych, personality assessment) - School or occupational records if functional impairment is reported - Legal records if forensic questions are involved - Collateral statements from family members or caregivers - Previous treatment records including therapy notes and medication trials - Substance use treatment records including PDMP query results --- ## Step 1: Identifying Information and Chief Complaint Document demographics (age, sex, gender identity, pronouns, race/ethnicity, primary language, marital status, living situation, employment/education status). Record the chief complaint in the patient's own words using direct quotation marks. Note referral source and reason for referral. Document who is present during the evaluation and the patient's level of cooperation. Identify the timeline of the presenting problem: onset, duration, severity trajectory, precipitating and exacerbating factors, alleviating factors, and prior treatment response. For each reported symptom, capture frequency, intensity, and functional impact. --- ## Step 2: Psychiatric and Medical History ### History of Present Illness (HPI) Construct a chronological narrative of the current episode. For each symptom cluster, map to DSM-5-TR diagnostic criteria. Quantify severity using validated instruments where available (PHQ-9 score for depression, GAD-7 for anxiety, PCL-5 for PTSD, AUDIT for alcohol use). ### Past Psychiatric History Document in structured format: - Previous diagnoses with approximate dates - Previous hospitalizations (voluntary/involuntary, facility, length of stay, reason for admission) - Previous medication trials with dosages, duration, response, and reason for discontinuation - History of psychotherapy (modality, duration, response) - History of ECT or other neuromodulation therapies - History of suicide attempts (method, lethality, medical intervention required, precipitant) - History of self-harm behaviors - History of aggressive or violent behavior ### Medical History Document active medical conditions, surgical history, allergies, current medications (including OTC and supplements), and relevant family medical history. Flag conditions that mimic psychiatric illness: thyroid disorders, autoimmune conditions, seizure disorders, TBI, sleep apnea, substance-induced syndromes. ### Substance Use History Screen all patients using AUDIT-C for alcohol and DAST-10 for drugs. Document: substance, route, frequency, quantity, age of first use, pattern of use, periods of sobriety, withdrawal history, prior treatment episodes. --- ## Step 3: Social and Developmental History Document developmental milestones (if relevant), childhood environment, history of abuse or neglect, educational history (highest level achieved, learning difficulties, behavioral issues), occupational history, military service, relationship history, current living situation, support system, legal history, religious/spiritual beliefs, and cultural factors affecting presentation or treatment preferences. Assess current functional status across domains: self-care, interpersonal relationships, occupational/academic performance, community engagement, and management of finances and legal affairs. --- ## Step 4: Mental Status Examination (MSE) Systematically document all MSE domains: - **Appearance:** Grooming, hygiene, attire, apparent age vs. stated age, distinguishing features, level of distress - **Behavior/Psychomotor:** Eye contact, cooperation, psychomotor agitation or retardation, abnormal movements (tardive dyskinesia screening), gait - **Speech:** Rate, rhythm, volume, tone, spontaneity, latency, articulation - **Mood:** Patient's subjective report in their own words - **Affect:** Range, intensity, congruence with mood, lability, appropriateness to content - **Thought Process:** Linear/logical, circumstantial, tangential, loose associations, flight of ideas, thought blocking, perseveration, neologisms - **Thought Content:** Suicidal ideation (active/passive, plan, intent, means), homicidal ideation, delusions (type and degree of conviction), obsessions, phobias, preoccupations, overvalued ideas - **Perceptions:** Hallucinations (auditory, visual, tactile, olfactory, gustatory — command hallucinations specifically), illusions, depersonalization, derealization - **Cognition:** Orientation (person, place, time, situation), attention/concentration, memory (immediate, recent, remote), fund of knowledge, abstraction, calculation - **Insight:** Patient's understanding of their illness and need for treatment (absent, poor, partial, good) - **Judgment:** Ability to make reasonable decisions about personal safety and welfare --- ## Step 5: Risk Assessment and Diagnostic Formulation ### Risk Assessment Conduct structured suicide risk assessment. Use the Columbia Suicide Severity Rating Scale (C-SSRS) or equivalent validated tool. Document: - Static risk factors (prior attempts, family history of suicide, demographic risk factors) - Dynamic risk factors (current ideation, hopelessness, substance use, recent losses, access to means) - Protective factors (social support, reasons for living, religious beliefs, engagement with treatment, children in the home) - Risk level determination (low, moderate, high, imminent) with clinical reasoning Document violence risk assessment when indicated using structured professional judgment tools (HCR-20 framework). ### Diagnostic Formulation Provide DSM-5-TR diagnoses with ICD-10-CM codes. For each diagnosis, document the specific criteria met. Use the biopsychosocial formulation model: - **Biological:** Genetics, medical comorbidities, substance effects, medications - **Psychological:** Personality traits, coping mechanisms, cognitive patterns, trauma history - **Social:** Stressors, support system, cultural factors, socioeconomic factors Include a differential diagnosis with reasoning for each diagnosis considered and ruled out. --- ## Checkpoint B: Post-Draft Alignment (Mandatory) 1. Does the evaluation address the specific referral question? 2. Are all DSM-5-TR criteria explicitly documented for each diagnosis rendered? 3. Is the risk assessment documented with both risk and protective factors and a clear risk-level determination? 4. Is the MSE complete across all required domains? 5. Does the treatment plan logically follow from the diagnostic formulation? --- ## Quality Audit - [ ] Chief complaint recorded in patient's own words - [ ] History of present illness includes onset, duration, severity, and functional impact - [ ] All prior medication trials documented with dosages and outcomes - [ ] Substance use screening completed and documented - [ ] MSE addresses all required domains with specific descriptors (not just "WNL") - [ ] Suicide risk assessment uses structured tool (C-SSRS or equivalent) - [ ] Protective factors documented alongside risk factors - [ ] Each DSM-5-TR diagnosis supported by documented criteria - [ ] Differential diagnosis explicitly addressed - [ ] Biopsychosocial formulation included - [ ] Treatment recommendations are specific and measurable - [ ] Collateral sources identified and noted whether obtained or unavailable - [ ] Cultural and linguistic factors addressed - [ ] Informed consent for evaluation documented - [ ] Evaluator credentials and date/time of evaluation recorded --- ## Guidelines 1. Never document a diagnosis without supporting criteria — each DSM-5-TR diagnosis must reference the specific symptoms and duration thresholds met during the evaluation. 2. Always screen for suicidal ideation regardless of presenting complaint — document the screening even when negative. 3. Use direct quotes for chief complaint and key patient statements rather than paraphrasing subjective experiences. 4. Flag all [VERIFY] items for information that could not be independently confirmed during the evaluation. 5. Document medication allergies separately from intolerances (true allergy with immune response vs. side effect). 6. When cognitive concerns are present, administer and score a validated screening tool (MoCA preferred over MMSE for sensitivity to mild cognitive impairment). 7. Document the patient's decision-making capacity implicitly through the evaluation or explicitly if capacity is in question. 8. Include a clear safety plan disposition for any patient with identified suicidal ideation, regardless of assessed risk level. --- Source attribution: CaseMark Original project: https://github.com/CaseMark/skills/blob/449269ec49b6a8f1b4614cea52aa44b2a76e4e94/skills/med/conducting-psychiatric-evaluations/SKILL.md License: Apache-2.0 License information: https://www.apache.org/licenses/LICENSE-2.0 Original upstream instructions; downloaded from Dave AI. ## Upstream license notice Apache License Version 2.0, January 2004 http://www.apache.org/licenses/ TERMS AND CONDITIONS FOR USE, REPRODUCTION, AND DISTRIBUTION 1. Definitions. "License" shall mean the terms and conditions for use, reproduction, and distribution as defined by Sections 1 through 9 of this document. "Licensor" shall mean the copyright owner or entity authorized by the copyright owner that is granting the License. "Legal Entity" shall mean the union of the acting entity and all other entities that control, are controlled by, or are under common control with that entity. For the purposes of this definition, "control" means (i) the power, direct or indirect, to cause the direction or management of such entity, whether by contract or otherwise, or (ii) ownership of fifty percent (50%) or more of the outstanding shares, or (iii) beneficial ownership of such entity. "You" (or "Your") shall mean an individual or Legal Entity exercising permissions granted by this License. "Source" form shall mean the preferred form for making modifications, including but not limited to software source code, documentation source, and configuration files. "Object" form shall mean any form resulting from mechanical transformation or translation of a Source form, including but not limited to compiled object code, generated documentation, and conversions to other media types. "Work" shall mean the work of authorship, whether in Source or Object form, made available under the License, as indicated by a copyright notice that is included in or attached to the work (an example is provided in the Appendix below). "Derivative Works" shall mean any work, whether in Source or Object form, that is based on (or derived from) the Work and for which the editorial revisions, annotations, elaborations, or other modifications represent, as a whole, an original work of authorship. For the purposes of this License, Derivative Works shall not include works that remain separable from, or merely link (or bind by name) to the interfaces of, the Work and Derivative Works thereof. "Contribution" shall mean any work of authorship, including the original version of the Work and any modifications or additions to that Work or Derivative Works thereof, that is intentionally submitted to the Licensor for inclusion in the Work by the copyright owner or by an individual or Legal Entity authorized to submit on behalf of the copyright owner. For the purposes of this definition, "submitted" means any form of electronic, verbal, or written communication sent to the Licensor or its representatives, including but not limited to communication on electronic mailing lists, source code control systems, and issue tracking systems that are managed by, or on behalf of, the Licensor for the purpose of discussing and improving the Work, but excluding communication that is conspicuously marked or otherwise designated in writing by the copyright owner as "Not a Contribution." "Contributor" shall mean Licensor and any individual or Legal Entity on behalf of whom a Contribution has been received by the Licensor and subsequently incorporated within the Work. 2. Grant of Copyright License. Subject to the terms and conditions of this License, each Contributor hereby grants to You a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable copyright license to reproduce, prepare Derivative Works of, publicly display, publicly perform, sublicense, and distribute the Work and such Derivative Works in Source or Object form. 3. Grant of Patent License. Subject to the terms and conditions of this License, each Contributor hereby grants to You a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable (except as stated in this section) patent license to make, have made, use, offer to sell, sell, import, and otherwise transfer the Work, where such license applies only to those patent claims licensable by such Contributor that are necessarily infringed by their Contribution(s) alone or by combination of their Contribution(s) with the Work to which such Contribution(s) was submitted. If You institute patent litigation against any entity (including a cross-claim or counterclaim in a lawsuit) alleging that the Work or a Contribution incorporated within the Work constitutes direct or contributory patent infringement, then any patent licenses granted to You under this License for that Work shall terminate as of the date such litigation is filed. 4. Redistribution. You may reproduce and distribute copies of the Work or Derivative Works thereof in any medium, with or without modifications, and in Source or Object form, provided that You meet the following conditions: (a) You must give any other recipients of the Work or Derivative Works a copy of this License; and (b) You must cause any modified files to carry prominent notices stating that You changed the files; and (c) You must retain, in the Source form of any Derivative Works that You distribute, all copyright, patent, trademark, and attribution notices from the Source form of the Work, excluding those notices that do not pertain to any part of the Derivative Works; and (d) If the Work includes a "NOTICE" text file as part of its distribution, then any Derivative Works that You distribute must include a readable copy of the attribution notices contained within such NOTICE file, excluding any notices that do not pertain to any part of the Derivative Works, in at least one of the following places: within a NOTICE text file distributed as part of the Derivative Works; within the Source form or documentation, if provided along with the Derivative Works; or, within a display generated by the Derivative Works, if and wherever such third-party notices normally appear. The contents of the NOTICE file are for informational purposes only and do not modify the License. You may add Your own attribution notices within Derivative Works that You distribute, alongside or as an addendum to the NOTICE text from the Work, provided that such additional attribution notices cannot be construed as modifying the License. You may add Your own copyright statement to Your modifications and may provide additional or different license terms and conditions for use, reproduction, or distribution of Your modifications, or for any such Derivative Works as a whole, provided Your use, reproduction, and distribution of the Work otherwise complies with the conditions stated in this License. 5. Submission of Contributions. Unless You explicitly state otherwise, any Contribution intentionally submitted for inclusion in the Work by You to the Licensor shall be under the terms and conditions of this License, without any additional terms or conditions. Notwithstanding the above, nothing herein shall supersede or modify the terms of any separate license agreement you may have executed with Licensor regarding such Contributions. 6. Trademarks. This License does not grant permission to use the trade names, trademarks, service marks, or product names of the Licensor, except as required for reasonable and customary use in describing the origin of the Work and reproducing the content of the NOTICE file. 7. Disclaimer of Warranty. Unless required by applicable law or agreed to in writing, Licensor provides the Work (and each Contributor provides its Contributions) on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied, including, without limitation, any warranties or conditions of TITLE, NON-INFRINGEMENT, MERCHANTABILITY, or FITNESS FOR A PARTICULAR PURPOSE. You are solely responsible for determining the appropriateness of using or redistributing the Work and assume any risks associated with Your exercise of permissions under this License. 8. Limitation of Liability. In no event and under no legal theory, whether in tort (including negligence), contract, or otherwise, unless required by applicable law (such as deliberate and grossly negligent acts) or agreed to in writing, shall any Contributor be liable to You for damages, including any direct, indirect, special, incidental, or consequential damages of any character arising as a result of this License or out of the use or inability to use the Work (including but not limited to damages for loss of goodwill, work stoppage, computer failure or malfunction, or any and all other commercial damages or losses), even if such Contributor has been advised of the possibility of such damages. 9. Accepting Warranty or Additional Liability. While redistributing the Work or Derivative Works thereof, You may choose to offer, and charge a fee for, acceptance of support, warranty, indemnity, or other liability obligations and/or rights consistent with this License. However, in accepting such obligations, You may act only on Your own behalf and on Your sole responsibility, not on behalf of any other Contributor, and only if You agree to indemnify, defend, and hold each Contributor harmless for any liability incurred by, or claims asserted against, such Contributor by reason of your accepting any such warranty or additional liability. END OF TERMS AND CONDITIONS Copyright 2025 CaseMark, Inc. Licensed under the Apache License, Version 2.0 (the "License"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. # Dave AI resource metadata Creator / publisher: CaseMark Original project: https://github.com/CaseMark/skills/blob/449269ec49b6a8f1b4614cea52aa44b2a76e4e94/skills/med/conducting-psychiatric-evaluations/SKILL.md Attribution basis: Source repository record Fields of work: Education & Research, Healthcare & Life Sciences Roles: Academic Writer, Clinical Research, Health Informatics, Medical Writer, Tutor / Instructor Specialties: Specialty not specified Tools: Tool not specified Country applicability: Country not specified Classification basis: Source catalog labels Instruction SHA-256: 2424117fb173b9229249e91a77ada0407d5aa2e65e8d6cc3e101e5eef499d73e